Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy - eBioMedicine
Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice | PLOS ONE
Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?
Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Is prime boost strategy a promising approach in HIV vaccine development | Semantic Scholar
Strategies and Implications for Prime-Boost Vaccination to Generate Memory CD8 T Cells | SpringerLink
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics
Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | Journal of Molecular Medicine
COVID-19 Vaccination Strategies: When Is One Dose Better Than Two? - AIP Publishing LLC
Frontiers | Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System
Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model
Full article: Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine - ScienceDirect
JCI Insight - Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
A Prime-Boost Strategy Using Virus-Like Particles Pseudotyped for HCV Proteins Triggers Broadly Neutralizing Antibodies in Macaques | Science Translational Medicine
Decisive Conditions for Strategic Vaccination against SARS-CoV-2 | medRxiv
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 | npj Vaccines
